The U.S. Department of Defense's Defense Health Agency has awarded a firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for services related to Cepheid's GeneXpert DX Systems in the Department of Pathology. The contract, valued at $326,745.25, has an ultimate completion date of September 10, 2025. Cepheid, the prime contractor, is not designated as a set-aside. The company has a history of providing diagnostic testing equipment,...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $199,744.50, is for a standard service agreement for Cepheid's GeneXpert system. The contract has an ultimate completion date of December 10, 2026. Cepheid is the prime contractor and there is no set-aside designation for this award. Cepheid has previously received numerous federal contract and grant awards from agencies...
The U.S. Defense Health Agency has awarded a firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of the CEPHEID GENEXPERT SYSTEM SERVICE. The contract, valued at $103,683.00, has an ultimate completion date of August 14, 2026. This award does not have a set-aside designation. Cepheid has been a prime contractor for various federal agencies, including the Department of Veterans Affairs (VA), the Defense Logistics...
The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the procurement of FY 22 new Cepheid GeneXpert Analyzers. The contract has a ceiling value of $79,000.00 and an ultimate completion date of September 22, 2027. The contract does not have a set-aside designation. Cepheid has received numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and...
The U.S. Department of Defense's Defense Logistics Agency has awarded a firm-fixed-price delivery order contract worth $3,210 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, which has no set-aside designation, is for the provision of equipment, reagents, consumables, and associated maintenance and support services related to Cepheid's GeneXpert diagnostic systems. This award is part of Cepheid's existing indefinite delivery contracts with the Department...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a Laboratory Cepheid GeneXpert Service Agreement. The $103,975.00 contract has a period of performance through June 18, 2028 and does not have a set-aside designation. Cepheid has received numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a service agreement to provide GeneXpert diagnostic equipment, reagents, consumables, and associated maintenance and support services. The contract has a ceiling value of $16,492.68 and a performance period ending on July 31, 2024. Cepheid has been awarded numerous prime federal contracts and indefinite-delivery vehicles (IDVs)...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a CEPHEID GENEXPERT LABORATORY SYSTEMS SERVICE AGREEMENT AND PREVENTIVE MAINTENANCE contract. The contract has a ceiling value of $78,830.00 and an ultimate completion date of January 31, 2029. The contract does not have a set-aside designation. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $123,607.98, is for a service agreement (GX16A1Y) with an ultimate completion date of April 12, 2027. Cepheid, which is registered in the System for Award Management (SAM.gov), will provide the DHA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to...
This is a $494,875.00 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for CEPHEID GENX SERVICES, with an ultimate completion date of April 9, 2028. The contract does not have a set-aside designation. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. Under this contract,...